Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
about
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Thunder and lightning: immunotherapy and oncolytic viruses collideRecombinant Newcastle disease virus as a vaccine vector for cancer therapyLocal production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejectionPhase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanomaDioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structureVaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanomaStimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer typesImproving the clinical impact of biomaterials in cancer immunotherapy.Viro-immune therapy: A new strategy for treatment of pancreatic cancerVaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.Going viral: a review of replication-selective oncolytic adenovirusesVaccines for pancreatic cancerLung cancer: a classic example of tumor escape and progression while providing opportunities for immunological interventionCombination regimens of radiation therapy and therapeutic cancer vaccines: mechanisms and opportunitiesImmunotherapy for prostate cancer: recent developments and future challengesTherapeutic cancer vaccines: past, present, and futureFrom bench to bedside: immunotherapy for prostate cancerImmunotherapy for primary brain tumors: no longer a matter of privilegeEvaluation of current cancer immunotherapy: hemato-oncologyThe optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translationCancer vaccinesFractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour ResponsePlasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in miceRecombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene.The Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentImmunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccinesImmunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: a randomized phase II trialReview: Application of Nanoparticles in Urothelial Cancer of the Urinary BladderIdentification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformationPhosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell functionA method to identify cDNAs based on localization of green fluorescent protein fusion productsA new triggering receptor expressed on myeloid cells (Trem) family member, Trem-like 4, binds to dead cells and is a DNAX activation protein 12-linked marker for subsets of mouse macrophages and dendritic cellsIdentification of a novel ligand-receptor pair constitutively activated by ras oncogenesH2-Mbeta 1 and H2-Mbeta 2 heterodimers equally promote clip removal in I-A(q) molecules from autoimmune-prone DBA/1 miceTrafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cellsInterplay between CD8α+ dendritic cells and monocytes in response to Listeria monocytogenes infection attenuates T cell responses
P2860
Q24531314-6251DD48-BE4D-4C6B-A61A-06BE3FF0F3E7Q24596171-5C41FCDB-83AC-4807-AFBE-3A8400B0AEB7Q24597894-3288601C-C8BE-4E08-AB54-5EC39C741357Q24602728-2938A357-50BD-4E5A-A80E-6CC8156CB741Q24630780-A40D3E02-EB7F-4978-8CF6-03F5014EA2F2Q24635643-601F5765-98C1-4600-B840-8848F0ADCDFDQ24650888-57353624-9FD3-448D-90ED-FC2AAAFCF1D8Q24684238-9A520289-3530-498F-8586-661428702651Q26745894-4907C1EB-D2CB-492D-A99B-1C0ECB802850Q26766267-D6E30A28-B786-4035-8AF6-D242E632BC94Q26774641-211AEE83-AC71-49C2-9439-55D8D1FB3775Q26796314-6EDE0CB1-5313-46C1-B5C0-526DB6CE0476Q26797520-AF65B36A-5D11-42E0-B10E-A8EB8EEA96DAQ26825850-4B62367F-BB23-4EF5-8AFA-528F6939C54FQ26850218-4A4DBB43-81BD-4BCD-8282-A3F5E398BEBDQ26851710-03C1BB00-8257-4BB4-845E-AB5374D5BF57Q26852388-09E2D19B-6C73-4F5A-B822-49BE93EFC1ECQ26863283-F9A6F9FD-72E3-40B3-8454-85131A3DAAF2Q26864390-60B1E72F-8F1B-493B-9B39-63AF91D5415AQ27002510-F82905B5-5EEC-46BC-A540-A6C436C042E1Q27006179-AA39F26C-36F6-4E31-9479-0A09748AE3CAQ27024106-82D6E586-4CA9-43EA-8E3B-2D7261FE317BQ27024438-66B0FBF9-8A62-4969-8DCA-0B1DE29DDE2BQ27334088-C3C52939-7B40-4809-BE15-14743FDC9929Q27340476-66C31B86-37E4-4308-91CB-ABC96A081EBEQ27469314-CB026B96-03EE-4458-B69D-4B6AB98817D8Q27469577-03A002D7-6D3C-49D5-9A83-7E9B7167F914Q28241308-E69F6342-F41B-41A3-913C-5B83D9EFF85AQ28273639-3615917A-C28C-4B60-BAF5-1FC2E389AC56Q28301672-6ECDC7CB-1EC1-441E-92DD-0C7D543738F3Q28364878-459859DE-F25C-449C-8FC3-9FF9FEE3C426Q28386921-DD4E2471-E486-4224-804E-724171944159Q28507547-0302FA51-6354-4D42-8A00-1D8F6DA4D4BEQ28510096-1A9B0506-71DB-4DC6-91C5-213D32B3AF1CQ28510457-B59F6525-7A67-48AD-88A7-A053126A8651Q28511097-EB49B236-BBCF-477C-9FC9-A62C487959F4Q28566795-69B55A81-E62F-4BE9-BD98-859A5892126FQ28585977-82D24E47-6C5D-4F9A-8687-C9CA5F39C21CQ28732041-47BCF2BB-A0BB-4CE6-A319-115124DAEF0BQ28740555-1668FF8A-F90F-4CC1-BEF0-91C927065166
P2860
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@ast
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@en
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@nl
type
label
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@ast
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@en
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@nl
prefLabel
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@ast
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@en
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@nl
P2093
P2860
P356
P1476
Vaccination with irradiated tu ...... g-lasting anti-tumor immunity.
@en
P2093
Golumbek P
Levitsky H
Mulligan RC
P2860
P304
P356
10.1073/PNAS.90.8.3539
P407
P577
1993-04-01T00:00:00Z